237880.KQ CLIO Cosmetics Co.Ltd
- Market cap
- KRW 193B
- P/E
- 6.5x
- P/B
- 0.74x
- ROE
- 15.9%
- Dividend yield
- 3.63%
- Fundamental score
- 3.4/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 237880.KQ undervalued?
Graham number237880.KQ trades 53.8% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CLIO Cosmetics Co.Ltd fundamental analysis
17 of 22 checks passedROE 1/2
Moderate return on equity (15.9%), between 10% and 20%.
ROA 1/1
Return on assets (12.4%) is above the industry median (1.3%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-51.3%) is not above the 5-year average (6.0% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (-51.3%) is above the industry median (-73.4%).
Revenue Growth 1/2
Revenue grew 6.5% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (2.8%), 40% or less.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 196.2x against interest expense, well covered.
PE vs Market 1/1
PE (6.5x) is below the market median (11.3x).
PE vs Industry 0/1
PE (6.5x) is above the industry median (5.6x).
PBV 0/1
Price to book (0.7x) is above the industry median (0.7x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 4.8, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 1.07, above 1.
Dividend Yield 1/2
Dividend yield (3.6%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 1/2
Dividends paid without a cut of more than 10% for 5 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 51.7%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
CLIO Cosmetics Co.Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CLIO Cosmetics Co.Ltd
CLIO Cosmetics Co.,Ltd engages in sales and distribution of cosmetics products and cosmetic tools in South Korea and internationally. It offers eye liner and brow, cushion, lipstick, lip tint, shading, cream, skincare mask, hair care products, as well as body and perfumes. The company offers its products under the CLIO, peripera, goodal, DERMATORY, TYPE NUMBER, TRUE RX, and Healing Bird brands through its CLUB CLIO shopping mall, as well as provides professional services thr…
Full company profileCLIO Cosmetics Co.Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CLIO Cosmetics Co.Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 194B | 194B | 187B | 250B | 218B | 233B | 272B | 331B | 351B | 329B | 330B |
| Gross Profit | 122B | 118B | 106B | 137B | 112B | 112B | 135B | 166B | 171B | 161B | 165B |
| Operating Income | 25.7B | 10.9B | -1.58B | 18.5B | 6.28B | 9.96B | 16.3B | 29.8B | 24.4B | 16.4B | 34.8B |
| EBITDA | - | - | - | - | - | - | 19.0B | 38.7B | 35.0B | 18.4B | 55.5B |
| Net Income | 20.8B | 7.93B | 996M | 2.94B | 9.59B | 9.27B | 10.1B | 27.7B | 27.9B | 13.6B | 41.3B |
| EPS | 1,241 | 472 | 60 | 177 | 578 | 549 | 578 | 1,582 | 1,590 | 774 | 2,358 |
| Balance Sheet | |||||||||||
| Total Assets | 241B | 233B | 189B | 237B | 215B | 234B | 244B | 280B | 295B | 299B | 334B |
| Total Liabilities | 100B | 88.3B | 47.4B | 91.4B | 61.9B | 66.8B | 53.5B | 65.9B | 61.5B | 58.4B | 76.4B |
| Shareholders' Equity | 141B | 145B | 141B | 145B | 153B | 167B | 190B | 214B | 235B | 243B | 260B |
| Cash & Short-term Investments | 153B | 133B | 61.1B | 83.4B | 55.2B | 87.2B | 91.1B | 124B | 131B | 99.5B | 126B |
| Total Debt | - | - | - | 6.52B | 3.27B | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 4.76B | -23.0B | 62.2B | 39.8B | 11.9B | 52.0B | 28.2B | 35.7B | 17.3B | 13.2B | 64.8B |
| Capital Expenditure | 4.95B | 6.27B | 13.2B | 11.8B | 907M | 3.65B | 29.6B | 869M | 719M | 772M | 244M |
| Free Cash Flow | - | - | - | 47.1B | 10.5B | 48.3B | -1.42B | 34.9B | 16.6B | 12.5B | 64.6B |
| Ratios | |||||||||||
| ROE | 14.8% | 5.5% | 0.7% | 2.0% | 6.3% | 5.5% | 5.3% | 13.0% | 11.9% | 5.6% | 15.9% |
| ROA | 8.6% | 3.4% | 0.5% | 1.2% | 4.5% | 4.0% | 4.2% | 9.9% | 9.4% | 4.5% | 12.4% |
| Net Profit Margin | 10.8% | 4.1% | 0.5% | 1.2% | 4.4% | 4.0% | 3.7% | 8.4% | 7.9% | 4.1% | 12.5% |
| Debt to Equity | - | - | - | 0.04x | 0.02x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
CLIO Cosmetics Co.Ltd dividends
- Dividend yield
- 3.63%
- Forward dividend
- 250.00 KRW
- Payout ratio
- 51.7%
- Ex-dividend date
- Dec 29, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 7.01B | 400 | 51.7% |
| 2024 | KRW 7.00B | 400 | 25.1% |
| 2023 | KRW 3.50B | 200 | 12.6% |
| 2022 | KRW 2.53B | 145 | 25.0% |
| 2021 | KRW 1.66B | 98 | 17.9% |
| 2020 | KRW 3.65B | 220 | 38.1% |
| 2019 | KRW 3.65B | 220 | 124.2% |
| 2018 | KRW 1.68B | 101 | 168.7% |
| 2017 | KRW 3.90B | 232 | 49.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns CLIO Cosmetics Co.Ltd
- Insiders 62.15%
- Institutions 1.25%
- Public & others 36.60%
- Shares outstanding 17.5M
- Free float 6.28M
CLIO Cosmetics Co.Ltd company profile
- Company name
- CLIO Cosmetics Co.Ltd
- Ticker
- 237880.KQ
- ISIN
- KR7237880000
- Exchange
- KOSDAQ
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 335
- Fiscal year end
- December
- Address
- 66, Wangsimni-ro, Seoul, South Korea
- Phone
- 82 8 0080 1510
- Website
- cliocosmetic.com
About CLIO Cosmetics Co.Ltd
CLIO Cosmetics Co.,Ltd engages in sales and distribution of cosmetics products and cosmetic tools in South Korea and internationally. It offers eye liner and brow, cushion, lipstick, lip tint, shading, cream, skincare mask, hair care products, as well as body and perfumes. The company offers its products under the CLIO, peripera, goodal, DERMATORY, TYPE NUMBER, TRUE RX, and Healing Bird brands through its CLUB CLIO shopping mall, as well as provides professional services through offline stores and online malls. CLIO Cosmetics Co.,Ltd was founded in 1993 and is based in Seoul, South Korea.
CLIO Cosmetics Co.Ltd management
5- Ms. Hyun-Ok HanCEO & Director · born 1960
- Ms. Eun-Young ShinHead of Marketing Division & Inside Director · born 1975
- Mr. Sung-Hoon YoonHead of Management Strategy Division & Director · born 1966
- Mr. Chan-Yong ParkHead of Global Business Division & Director · born 1966
- Ms. Hye-Joon ParkHead of Design Division & Inside Director · born 1973